Australia markets close in 6 hours 8 minutes

Elixinol Wellness Limited (ELLXF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0044+0.0011 (+31.82%)
At close: 01:57PM EDT

Elixinol Wellness Limited

680 George Street
Level 12
Sydney, NSW 2000
61 2 8280 7355

IndustryDrug Manufacturers - Specialty & Generic
Full-time employees

Key executives

NameTitlePayExercisedYear born
Ms. Josephine LorenzGlobal CFO & Joint Company Secretary220.23kN/AN/A
Glen ZurcherAccount Director of Investor Relations DepartmentN/AN/AN/A
Ms. Natalie ButlerHead of Marketing & Executive DirectorN/AN/AN/A
Ms. Sarah Prince ACIS, BA, GrdDipCorpGov, LLBJoint Company SecretaryN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Elixinol Wellness Limited, through its subsidiaries, engages in the manufacture and distribution of hemp derived nutraceuticals, skincare, and food products in the Americas, Europe, and Australia. It offers hemp derived cannabidiol and food products, dietary supplements, topicals, and skincare products. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is headquartered in Sydney, Australia.

Corporate governance

Elixinol Wellness Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.